Major depressive disorder: new clinical, neurobiological, and treatment perspectives

Kupfer, David J, Frank, Ellen and Phillips, Mary L 2012. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. The Lancet 379 (9820) , pp. 1045-1055. 10.1016/S0140-6736(11)60602-8

Full text not available from this repository.

Abstract

In this Seminar we discuss developments from the past 5 years in the diagnosis, neurobiology, and treatment of major depressive disorder. For diagnosis, psychiatric and medical comorbidity have been emphasised as important factors in improving the appropriate assessment and management of depression. Advances in neurobiology have also increased, and we aim to indicate genetic, molecular, and neuroimaging studies that are relevant for assessment and treatment selection of this disorder. Further studies of depression-specific psychotherapies, the continued application of antidepressants, the development of new treatment compounds, and the status of new somatic treatments are also discussed. We address two treatment-related issues: suicide risk with selective serotonin reuptake inhibitors, and the safety of antidepressants in pregnancy. Although clear advances have been made, no fully satisfactory treatments for major depression are available.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Elsevier
ISSN:	0140-6736
Last Modified:	28 Oct 2015 14:28
URI:	https://orca.cardiff.ac.uk/id/eprint/79909

Citation Data

Cited 550 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item